Chemstructure (Image 01)
Brinzolamide Suspension/ Drops
Product Images NDC 24208-464
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brinzolamide (NDC 24208-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton10ml (Image 02)
This is a description of Brinzolamide Ophthalmic Suspension, a prescription medication for use in the eyes only. The active ingredient in the medication is 10mg of Brinzolamide, and its inactive ingredients include carbomer 74P, edetate disodum, manniol, sodium chloride, yloxapol, water for injection, with hydrochloric acid and/or sodium hydrosite to adjust pH. The medication is distributed by Bausch & Lomb Americas and should be stored at 2-30°C (39 to 86°F). The medication comes in a 10mL bottle, with specific instructions to shake well before use, and should be administered three times a day as drops in the affected eye(s). A warning is given not to touch the dropper tip to any surface to avoid contamination, and the product should be kept out of reach of children.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
